Suchergebnisse - "Pinato, David J"

PubPharm (284)

51

Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer

enthalten in: Nature medicine | 2023

von van de Haar, J. | Ma, X. | Ooft, S. | +47

CommentIn: Nat Rev Gastroenterol Hepatol. 2023 May;20(5):269. - PMID 37012321

52

Local and systemic therapy in liver cancer : the quest for synergy

enthalten in: The lancet. Gastroenterology & hepatology | 2023

von Pinter, M. | Pinato, D.

CommentOn: Lancet Gastroenterol Hepatol. 2023 Feb;8(2):169-178. - PMID 36529152

53

NASH and Hepatocellular Carcinoma : Immunology and Immunotherapy

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Pinter, M. | Pinato, D. | Ramadori, P. | +1

54

The Effects of GCSF Primary Prophylaxis on Survival Outcomes and Toxicity in Patients with Advanced Non-Small Cell Lung Cancer on First-Line Chemoimmunotherapy : A Sub-Analysis of the Spinnaker Study

enthalten in: International journal of molecular sciences | 2023

von Anpalakhan, S. | Huddar, P. | Behrouzi, R. | +14

55

Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma

enthalten in: JHEP reports : innovation in hepatology | 2023

von Scheiner, B. | Roessler, D. | Phen, S. | +35

56

Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors

enthalten in: Frontiers in oncology | 2023

von Wu, Y. | van Hyfte, G. | Özbek, U. | +22

57

Immunotherapy-related adverse events in real-world patients with advanced non-small cell lung cancer on chemoimmunotherapy : a Spinnaker study sub-analysis

enthalten in: Frontiers in oncology | 2023

von Anpalakhan, S. | Huddar, P. | Behrouzi, R. | +16

58

Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma

enthalten in: JHEP reports | January 2023

von Scheiner, B. | Roessler, D. | Phen, S. | +35

59

Association of Machine Learning-Based Assessment of Tumor-Infiltrating Lymphocytes on Standard Histologic Images With Outcomes of Immunotherapy in Patients With NSCLC

enthalten in: JAMA oncology | 2023

von Rakaee, M. | Adib, E. | Ricciuti, B. | +19

CommentIn: JAMA Oncol. 2023 Jan 1;9(1):60-61. - PMID 36394848

60

Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma : An international observational study

enthalten in: Liver International | 2023

von Talbot, T. | D'Alessio, A. | Pinter, M. | +33